Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib Study for Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
T-cell Depleted Alternative Donor Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Intraosseous Infusion of Unrelated Cord Blood Grafts
- Status
- TERMINATED
- Phase
- NA
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
SCRI Tissue Testing Registry
- Status
- TERMINATED
- Phase
- N/A
NOV-002 in Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
- Status
- UNKNOWN
- Phase
- PHASE2
Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study of Iron Overload in Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- N/A
Combined Haploidentical-Cord Blood Transplantation for Adults and Children
- Status
- COMPLETED
- Phase
- NA
Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
- Status
- COMPLETED
- Phase
- PHASE1